Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Inclusion Criteria: * Antiretroviral naïve * HIV RNA \<100,000 copies/mL * CD4 cell count \>100 cells/mL at screening * with Karnofsky Score \> 70 * If female, * non-pregnant and * not breastfeeding * No AIDS opportunistic infection within 30 days of screening Exclusion Criteria: * Subject with an HIV primo-infection status * Recent history of drug and/or alcohol abuse * History of psychiatric illness * If presence of the following mutations : * in the protease : one among 32,47,48,50,82,84,90 * OR more than 3 mutations from the other points of the LPV mutation score:10,20,24,46,53,54,63,71 * in the reverse transcriptase : 215 or 184. * If abnormal laboratory results such as : * Hb\<8 g/dl * Absolute neutrophil count\<750 cells/µl * Platelet count\<50 000/ml